Unrecognized Tax Benefits of AbbVie Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
AbbVie Inc. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • AbbVie Inc. Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $4,505,000,000, a 2.4% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

AbbVie Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $4,505,000,000 +$104,000,000 +2.4% 31 Dec 2025 10-K 20 Feb 2026 2025 FY
Q4 2024 $4,401,000,000 -$1,361,000,000 -24% 31 Dec 2024 10-K 20 Feb 2026 2025 FY
Q4 2023 $5,762,000,000 +$92,000,000 +1.6% 31 Dec 2023 10-K 20 Feb 2026 2025 FY
Q4 2022 $5,670,000,000 +$181,000,000 +3.3% 31 Dec 2022 10-K 20 Feb 2026 2025 FY
Q4 2021 $5,489,000,000 +$225,000,000 +4.3% 31 Dec 2021 10-K 14 Feb 2025 2024 FY
Q4 2020 $5,264,000,000 +$2,603,000,000 +98% 31 Dec 2020 10-K 20 Feb 2024 2023 FY
Q4 2019 $2,661,000,000 -$191,000,000 -6.7% 31 Dec 2019 10-K 17 Feb 2023 2022 FY
Q4 2018 $2,852,000,000 +$151,000,000 +5.6% 31 Dec 2018 10-K 18 Feb 2022 2021 FY
Q4 2017 $2,701,000,000 +$1,533,000,000 +131% 31 Dec 2017 10-K 19 Feb 2021 2020 FY
Q4 2016 $1,168,000,000 +$214,000,000 +22% 31 Dec 2016 10-K 21 Feb 2020 2019 FY
Q4 2015 $954,000,000 +$533,000,000 +127% 31 Dec 2015 10-K 27 Feb 2019 2018 FY
Q4 2014 $421,000,000 +$174,000,000 +70% 31 Dec 2014 10-K 16 Feb 2018 2017 FY
Q4 2013 $247,000,000 -$893,000,000 -78% 31 Dec 2013 10-K 17 Feb 2017 2016 FY
Q4 2012 $1,140,000,000 +$101,000,000 +9.7% 31 Dec 2012 10-K 19 Feb 2016 2015 FY
Q4 2011 $1,039,000,000 -$606,000,000 -37% 31 Dec 2011 10-K 20 Feb 2015 2014 FY
Q4 2010 $1,645,000,000 31 Dec 2010 10-K 21 Feb 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.